| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 10,074 | 10,299 | 10,647 | 10,404 | | Cost of Revenue | 2,085 | 2,177 | 2,351 | 2,581 | | | Gross Profit | 7,989 | 8,122 | 8,296 | 7,823 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,907 | 3,300 | 3,098 | 3,206 | | Non Recurring | 3,138 | (80) | 80 | 3,219 | | Others | (1,342) | 2,165 | 701 | 600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,286 | 2,737 | 4,417 | 798 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,286 | 2,737 | 4,417 | 798 | | Interest Expense | 2,591 | 2,597 | 2,755 | 2,775 | | Income Before Tax | (305) | 140 | 1,662 | (1,977) | | Income Tax Expense | (542) | 269 | (25) | 438 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 237 | (129) | 1,687 | (2,415) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 237 | (129) | 1,687 | (2,415) | | Preferred Stock And Other Adjustments | (102) | (121) |
-
|
-
| | | Net Income Applicable To Common Shares | $135 | ($250) | $1,687 | ($2,415) |
|
0.14% Nasdaq 
0.27%
Income Statement
